statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eli Lilly's first-quarter report shows a revenue surge of 26%, beating EPS expectations. Analysts maintain a bullish outlook.

 Latest Ratings for LLY
 DateFirmActionFromTo Feb 2022Morgan...

Eli Lilly 'On Its Way' To $1 Trillion Market Cap, Analysts Say: It's A 'Have' In A Sea Of 'Have Nots'

Trade Tracker: Joe Terranova sells Eli Lilly...

Trade Tracker: Joe Terranova sells Eli Lilly

Latest Ratings for LLY
 DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022MizuhoMaintainsBuy Jan 2022Morgan StanleyMaintainsOverweight
 View More Analyst Ratings for LLY...

What 23 Analyst Ratings Have To Say About Eli Lilly and Co

Investopedia

 Key TakeawaysThe S&P 500 dropped 1.6% on Tuesday, April 30, 2024, cementing its first monthly loss of the year as data on wage growth reignited inflation concerns.GE HealthCare...

S&P 500 Gains and Losses Today: GE HealthCare Stock Plunges After Earnings Miss

Eli Lilly boosts production for obesity and diabetes drugs, reports mixed Q1 results. Expectations for supply growth in 2024 outlined. Insights into payor access and reimbursement strategies...

Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and Diabetes Drugs

Potential for Weight-Loss Drugs Boosts Eli Lilly...

Potential for Weight-Loss Drugs Boosts Eli Lilly

Eli Lilly stock soars on earnings, 'off-the-charts' demand for weight-loss drugs...

Eli Lilly stock soars on earnings, 'off-the-charts' demand for weight-loss drugs

Scott Olson / Staff / Getty Images

 Key TakeawaysU.S. equities dropped at midday as the market reacted to the latest earnings news and a report showing employment costs rose more than expected in...

Top Stock Movers Now: Eli Lilly, GE HealthCare, 3M, and More

Eli Lilly stock jumped 5% during Tuesday morning trading to about $773 a share after the pharma giant reported better-than-expected sales of its weight loss drug Zepbound in the first quarter of...

Weight loss drugs are so hot that Eli Lilly is expecting $2 billion more in sales this year

Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Volume	2.8M
52-Wk High	$800.78
52-Wk Low	$419.80

LLY Lilly(Eli) & Co

About

Feed

News

Sentiment

Earnings

Fundamentals